PMID: 16572964Apr 1, 2006

Multiple myeloma: treatment options for an incurable disease

The Journal of the Association of Physicians of India
S R Pandit


Multiple myeloma remains a challenge for the treating physician, with extremely low complete response rates (5-10%) to conventional induction therapy. High dose therapy with autologous hematopoietic stem cell transplant results in improved response, event-free and overall survival and should be considered the standard of care for patients who are candidates for transplantation. Several newer treatment option are now available.

Related Concepts

TNM Staging System
Incurable Diseases
Transplantation Aspects
Hematopoietic Stem Cells
Multiple Myeloma
Transplanted Tissue

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.